DRNA - Dicerna Pharmaceuticals (DRNA) CEO Doug Fambrough on Q1 2021 Results - Earnings Call Transcript
Dicerna Pharmaceuticals, Inc. (DRNA) Q1 2021 Earnings Conference Call May 06, 2021, 04:30 PM ET Company Participants Will Grammig - Stern IR Doug Fambrough - President, CEO Doug Pagan - CFO Sheeram Aradhye - CMO Jim Weissman - COO Rob Ciappenelli - CCO Bob Brown - CSO Shreeram Aradhye - EVP & CMO Conference Call Participants Jonathan Miller - Evercore Luca Issi - RBC Capital Yigal Nochomovitz - Citigroup Mayank Mamtani - B. Riley Securities Robyn Karnauskas - Truist Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the Dicerna Pharmaceuticals First Quarter 2021 Earnings Conference Call. As a reminder, this conference call is being recorded at the company's request. I will now turn the call over to your host, Will Grammig of Stern IR. Please go ahead. Will Grammig Thank you, operator. Good afternoon, everyone, and thank you for joining us to review Dicerna's first quarter 2021 financial
For further details see:
Dicerna Pharmaceuticals (DRNA) CEO Doug Fambrough on Q1 2021 Results - Earnings Call Transcript